Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sigmascreening logo — Advancing breast cancer screening with innovative digital ma...

Sigmascreening

Advancing breast cancer screening with innovative digital mammography solutions from Amsterdam

Founded 2010 Series Unknown Total: $1.00M Biotechnology, Medical Devices

General Information

Company Name Sigmascreening
Founded Year 2010
Industries Biotechnology, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Sigmascreening moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sigmascreening

Sigmascreening is a medical device company based in Amsterdam that specializes in creating innovative products for breast cancer screening. Established in 2010 as a spin-off from the Academic Medical Center Amsterdam (AMC Amsterdam), the company is dedicated to enhancing digital mammography, the standard method for breast cancer detection. Sigmascreening is actively working on several new developments to make significant improvements in this crucial area of healthcare. The company received a €1.00M Venture Round investment on 23 June 2015 from DFZ Participaties.

Taxonomy: Amsterdam, Sigmascreening, medical device company, breast cancer screening, innovative products, digital mammography, Academic Medical Center Amsterdam, AMC Amsterdam, spin-off, cancer detection, technology, health innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 23 Jun 2015
Private Equity Round •••••• 3
Investor Investor
•••• •••• 		07 Mar 2014
Series A •••••• 1
Investor
06 Oct 2010
Seed Round •••••• 1
Investor
17 Jul 2010

Sigmascreening Alternatives & Competitors

Sigmascreening vs
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Netherlands B.V.

Empowering hope in blood cancer treatment with innovative therapies to meet high-unmet medical needs...

Post Ipo Equity
2 employees
Biopharma, Biotechnology
Sigmascreening vs
Qview Medical, Inc.
Qview Medical, Inc. United States

Pioneering breast cancer detection with advanced ultrasound image analysis, enhancing early diagnosi...

Series B
2 employees
Health Care, Information Technology
Sigmascreening vs
Atossa Therapeutics
Atossa Therapeutics

Providing innovative treatments for pre-cancerous breast conditions and early-stage breast cancer.

Post Ipo Equity
51-200 employees
Biotechnology, Health Care

FAQ About Sigmascreening

Advancing breast cancer screening with innovative digital mammography solutions from Amsterdam
Sigmascreening was founded in 2010.
Sigmascreening operates in the following industries: Biotechnology, Medical Devices.
Sigmascreening has completed 4 funding rounds, raising a total of $1.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Sigmascreening include Kiadis Pharma Netherlands B.V., Qview Medical, Inc., Atossa Therapeutics, Breast Cancer Trials, Cianna Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sigmascreening and Kiadis Pharma Netherlands B.V. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sigmascreening and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy